Monica Clifford1, James Twigg, Chris Upton. 1. Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 3P6, Canada. mcliffor@uvic.ca
Abstract
BACKGROUND: Influenza A virus genomes are comprised of 8 negative strand single-stranded RNA segments and are thought to encode 11 proteins, which are all translated from mRNAs complementary to the genomic strands. Although human, swine and avian influenza A viruses are very similar, cross-species infections are usually limited. However, antigenic differences are considerable and when viruses become established in a different host or if novel viruses are created by re-assortment devastating pandemics may arise. RESULTS: Examination of influenza A virus genomes from the early 20th Century revealed the association of a 167 codon ORF encoded by the genomic strand of segment 8 with human isolates. Close to the timing of the 1948 pseudopandemic, a mutation occurred that resulted in the extension of this ORF to 216 codons. Since 1948, this ORF has been almost totally maintained in human influenza A viruses suggesting a selectable biological function. The discovery of cytotoxic T cells responding to an epitope encoded by this ORF suggests that it is translated into protein. Evidence of several other non-traditionally translated polypeptides in influenza A virus support the translation of this genomic strand ORF. The gene product is predicted to have a signal sequence and two transmembrane domains. CONCLUSION: We hypothesize that the genomic strand of segment 8 of encodes a novel influenza A virus protein. The persistence and conservation of this genomic strand ORF for almost a century in human influenza A viruses provides strong evidence that it is translated into a polypeptide that enhances viral fitness in the human host. This has important consequences for the interpretation of experiments that utilize mutations in the NS1 and NEP genes of segment 8 and also for the consideration of events that may alter the spread and/or pathogenesis of swine and avian influenza A viruses in the human population.
BACKGROUND:Influenza A virus genomes are comprised of 8 negative strand single-stranded RNA segments and are thought to encode 11 proteins, which are all translated from mRNAs complementary to the genomic strands. Although human, swine and avian influenza A viruses are very similar, cross-species infections are usually limited. However, antigenic differences are considerable and when viruses become established in a different host or if novel viruses are created by re-assortment devastating pandemics may arise. RESULTS: Examination of influenza A virus genomes from the early 20th Century revealed the association of a 167 codon ORF encoded by the genomic strand of segment 8 with human isolates. Close to the timing of the 1948 pseudopandemic, a mutation occurred that resulted in the extension of this ORF to 216 codons. Since 1948, this ORF has been almost totally maintained in human influenza A viruses suggesting a selectable biological function. The discovery of cytotoxic T cells responding to an epitope encoded by this ORF suggests that it is translated into protein. Evidence of several other non-traditionally translated polypeptides in influenza A virus support the translation of this genomic strand ORF. The gene product is predicted to have a signal sequence and two transmembrane domains. CONCLUSION: We hypothesize that the genomic strand of segment 8 of encodes a novel influenza A virus protein. The persistence and conservation of this genomic strand ORF for almost a century in human influenza A viruses provides strong evidence that it is translated into a polypeptide that enhances viral fitness in the human host. This has important consequences for the interpretation of experiments that utilize mutations in the NS1 and NEP genes of segment 8 and also for the consideration of events that may alter the spread and/or pathogenesis of swine and avian influenza A viruses in the human population.
Authors: A A Schäffer; L Aravind; T L Madden; S Shavirin; J L Spouge; Y I Wolf; E V Koonin; S F Altschul Journal: Nucleic Acids Res Date: 2001-07-15 Impact factor: 16.971
Authors: W Chen; P A Calvo; D Malide; J Gibbs; U Schubert; I Bacik; S Basta; R O'Neill; J Schickli; P Palese; P Henklein; J R Bennink; J W Yewdell Journal: Nat Med Date: 2001-12 Impact factor: 53.440
Authors: C F Basler; A H Reid; J K Dybing; T A Janczewski; T G Fanning; H Zheng; M Salvatore; M L Perdue; D E Swayne; A García-Sastre; P Palese; J K Taubenberger Journal: Proc Natl Acad Sci U S A Date: 2001-02-27 Impact factor: 11.205
Authors: J Talon; M Salvatore; R E O'Neill; Y Nakaya; H Zheng; T Muster; A García-Sastre; P Palese Journal: Proc Natl Acad Sci U S A Date: 2000-04-11 Impact factor: 11.205
Authors: Gary K Geiss; Mirella Salvatore; Terrence M Tumpey; Victoria S Carter; Xiuyan Wang; Christopher F Basler; Jeffery K Taubenberger; Roger E Bumgarner; Peter Palese; Michael G Katze; Adolfo García-Sastre Journal: Proc Natl Acad Sci U S A Date: 2002-07-29 Impact factor: 11.205
Authors: Edwin D Kilbourne; Catherine Smith; Ian Brett; Barbara A Pokorny; Bert Johansson; Nancy Cox Journal: Proc Natl Acad Sci U S A Date: 2002-07-22 Impact factor: 11.205
Authors: Heather D Hickman; Jacqueline W Mays; James Gibbs; Ivan Kosik; Javier G Magadán; Kazuyo Takeda; Suman Das; Glennys V Reynoso; Barbara F Ngudiankama; JiaJie Wei; John P Shannon; Daniel McManus; Jonathan W Yewdell Journal: J Immunol Date: 2018-07-16 Impact factor: 5.422